PedAM
Pediatric Disease Annotations & Medicines
| Disease | dementia |
| Symptom | C0030567|parkinson\'s |
| Sentences | 65 |
| PubMedID- 21560084 | Recent genetic, neurochemical and neuropsychological experiments robustly confirm a link between dementia associated with parkinson's disease and dementia with lewy bodies. |
| PubMedID- 23208306 | Spectroscopic changes associated with mild cognitive impairment and dementia in parkinson's disease. |
| PubMedID- 25412696 | In lewy body disease (lbd) such as dementia with lbs and parkinson's disease, several lines of evidence show that disrupted proteolysis occurs. |
| PubMedID- 22832236 | Background: although donepezil, an acetylcholinesterase inhibitor, has been proved to be effective in ameliorating cognitive impairment in parkinson's disease with dementia (pdd), the responsiveness of patients to donepezil therapy varies. |
| PubMedID- 21658235 | The identification of these mutations contributes to the contention as to whether the so-called lewy body disorders (parkinson's disease, parkinsonism with dementia, and dementia with lewy bodies) represent a continuum or have to be considered as distinct diseases . |
| PubMedID- 20571039 | The estimated life expectancy in a community cohort of parkinson's disease patients with and without dementia, compared with the uk population. |
| PubMedID- 23308173 | Patients diagnosed with pdd met the clinical diagnostic criteria for dementia associated with parkinson's disease . |
| PubMedID- 25739491 | Genetic factors associated with dementia in parkinson's disease (pd). |
| PubMedID- 24685119 | Like ace, moca are useful to detect dementia with parkinson's disease, and for more detailed testing for those scoring relatively highly in shorter cognitive tests. |
| PubMedID- 22419314 | Background: previous cochrane reviews have considered the use of cholinesterase inhibitors in both parkinson's disease with dementia (pdd) and dementia with lewy bodies (dlb). |
| PubMedID- 26101858 | This exclusion criteria was particularly important to minimize the influence of cerebro-vascular pathologies on the cognitive deficits.met the criteria for dementia with lewy bodies, parkinson's disease with dementia, pick's disease, creutzfeldt-jacob disease.showed hippocampal sclerosis, tauopathies, or primary or secondary brain tumors. |
| PubMedID- 22311215 | Metabolic syndrome and dementia associated with parkinson's disease: impact of age and hypertension. |
| PubMedID- 24296865 | dementia in parkinson's disease (pd) is a serious health issue and a major concern for many patients. |
| PubMedID- 26058246 | Depression and dementia in parkinson's disease. |
| PubMedID- 21847324 | In recent times parkinson's disease with dementia (pdd) along with dementia with lewy body (dlb), collectively called cortical lewy body disease comprises 10%–15% of all degenerative dementia and is only second to alzheimer's disease (ad) in terms of prevalence. |
| PubMedID- 23691698 | The prevalence and the associated factors of dementia in patients with parkinson's disease at maharat nakhon ratchasima hospital. |
| PubMedID- 20187235 | Over the last decade, the importance of cognitive impairment and dementia in parkinson's disease (pdd) has been increasingly recognized. |
| PubMedID- 26173861 | Mild cognitive impairment in parkinson's disease is associated with progression to dementia (parkinson's disease dementia) in a majority of patients. |
| PubMedID- 22541783 | Objective: lewy-related pathology is the characteristic feature of parkinson's disease with and without dementia and dementia with lewy bodies (dlb). |
| PubMedID- 24757114 | Cognitive impairment and dementia in parkinson's disease: practical issues and management. |
| PubMedID- 22042172 | dementia in parkinson's disease: a brazilian sample. |
| PubMedID- 24123241 | dementia in parkinson's disease: usefulness of the pill questionnaire. |
| PubMedID- 23470887 | Severe olfactory dysfunction is a predictor of dementia with parkinson's disease. |
| PubMedID- 24757112 | The recent formalization of clinical criteria for parkinson's disease with dementia (pdd) codifies many studies on this topic, including those assessing biological correlates. |
| PubMedID- 21211363 | Methods: cognitive function was examined in parkinson's disease with dementia (pdd) patients (n = 30), alzheimer's disease (ad) patients (n = 30) and healthy elderly control subjects (n = 60). |
| PubMedID- 22595371 | The neuropathological diagnoses were parkinson's disease with dementia and pathological aging. |
| PubMedID- 25024059 | Objective: aim of this study was to identify risk factors for the development of dementia in patients with parkinson's disease (pd). |
| PubMedID- 23610582 | rivastigmine is also indicated for patients with dementia associated with parkinson's disease (pd). |
| PubMedID- 21412836 | Mild cognitive impairment (mci) may predict future development of dementia in parkinson's disease (pd). |
| PubMedID- 22250611 | Gender, however, was not correlated with dementia in parkinson's disease. |
| PubMedID- 26394760 | Neurosin (kallikrein-6) is a serine protease capable of cleaving alpha-syn in the cns, and we have previously shown that lentiviral (lv) vector delivery of neurosin into the brain of a mouse model of dementia with lewy body/ parkinson's disease reduces the accumulation of alpha-syn and improves neuronal synaptic integrity. |
| PubMedID- 24018606 | Conclusions: these preliminary results suggest that rotigotine at low dose might improve non-motor symptoms of wo in elderly patients suffering from parkinson's disease with dementia, without raising major safety issues. |
| PubMedID- 21335570 | dementia in parkinson's disease: a 20-year neuropsychological study (sydney multicentre study). |
| PubMedID- 21596773 | The relative importance of lewy- and alzheimer-type pathologies to dementia in parkinson's disease remains unclear. |
| PubMedID- 22360775 | Their effect in cognitive decline and dementia associated with parkinson's disease (pd) is still unclear. |
| PubMedID- 20094726 | Fluctuating cognition and different cognitive and behavioural profiles in parkinson's disease with dementia: comparison of dementia with lewy bodies and alzheimer's disease. |
| PubMedID- 25887557 | Clonidine has been studied in outpatients with alzheimer's dementia and in patients with parkinson's disease . |
| PubMedID- 20563819 | The synaptic pathology of alpha-synuclein aggregation in dementia with lewy bodies, parkinson's disease and parkinson's disease dementia. |
| PubMedID- 20155863 | The diagnosis of parkinson's disease with dementia (pdd) is currently based on clinical criteria (dsm-iv, mds-task force). |
| PubMedID- 20205140 | The dementia associated with parkinson's disease is specifically related with neuropsychiatric signs and symptoms, which may have three possible explanations: disorders affecting the mesolimbic pathways, diffuse limbic and cortical compromise, or associated alzheimer-type phenomenology. |
| PubMedID- 21370709 | Tackling dementia in patients with parkinson's disease. |
| PubMedID- 22093337 | Therefore, the mmse would not be recommended as an instrument for use in screening for dementia among patients with parkinson's disease . |
| PubMedID- 21199444 | dementia in parkinson's disease (pd-d) has only been acknowledged in the recent three decades, but research in this field has accelerated. |
| PubMedID- 22322798 | Rapid eye movement sleep behavior disorder and risk of dementia in parkinson's disease: a prospective study. |
| PubMedID- 23551405 | Background: rivastigmine is a cholinesterase inhibitor for treatment of mild to moderate alzheimer's disease (ad) and dementia associated with parkinson's disease. |
| PubMedID- 23404139 | Objectives: we investigated the relationship between white-matter alteration and cognitive status in parkinson's disease (pd) with and without dementia by using diffusion tensor imaging. |
| PubMedID- 22265943 | Subjects and methods: we evaluated insulin resistance, glucose and insulin levels after a 2-h-oral-glucose-tolerance-test in 53 parkinson's disease with dementia and 57 with parkinson's disease without dementia, with normal fasting glucose. |
| PubMedID- 20064549 | Emotional changes, impairment of object recognition, and neuroinflammation are seen in parkinson's disease with dementia (pdd). |
| PubMedID- 24987465 | Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in parkinson's disease with dementia and dementia with lewy bodies compared to alzheimer's disease. |
| PubMedID- 24661498 | Effects of donepezil dose escalation in parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study. |
Page: 1 2